06/02/2026
Serena Williams’ revelation about using GLP-1 medication has sparked headlines, and hard questions. Can celebrity openness destigmatise obesity treatment without driving over-demand and inequity?
https://medcpd.com/serena-williams-glp-1s-and-the-risk-of-normalisation/